tiprankstipranks
Palatin announces results from PL9643 MELODY-1 pivotal Phase 3 clinical trial
PremiumThe FlyPalatin announces results from PL9643 MELODY-1 pivotal Phase 3 clinical trial
2M ago
Palatin reports Q2 EPS (56c), consensus (20c)
PremiumThe Fly
Palatin reports Q2 EPS (56c), consensus (20c)
2M ago
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
2M ago
Palatin Technologies Issues Unregistered Equity Securities Warrants
PremiumCompany AnnouncementsPalatin Technologies Issues Unregistered Equity Securities Warrants
3M ago
Palatin Technologies Strikes Deal for $9.2M Capital Boost
PremiumCompany Announcements
Palatin Technologies Strikes Deal for $9.2M Capital Boost
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171M
PremiumThe Fly
Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171M
4M ago
Palatin: NYSE American accepts listing standards compliance plan
PremiumThe Fly
Palatin: NYSE American accepts listing standards compliance plan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100